Nosocomial transmission of community-associated methicillin-resistant Staphylococcus aureus in Danish Hospitals
Objectives The emergence of community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) has changed the epidemiology of MRSA infections worldwide. In contrast to hospital-associated MRSA (HA-MRSA), CA-MRSA more frequently affects healthy individuals, both with and without recent healthcare exposure. Despite obvious epidemiological differences, it is unknown whether differences in nosocomial transmissibility exist. We have, therefore, quantified the transmissibility, expressed by the single admission reproduction number (RA), of CA-MRSA and HA-MRSA in hospital settings in Denmark. Methods MRSA index cases and secondary cases were investigated in four hospitals in the Copenhagen area. Index cases were defined as non-isolated, non-screened patients with MRSA, and secondary cases were defined as persons carrying MRSA isolates—identical to that of the corresponding index—as identified through contact screening. CA-MRSA and HA-MRSA were categorised upon genotyping [CA-MRSA: t008-ST8, PVL+; t019-ST30, PVL+; t127-ST1, PVL+; t044-ST80, PVL+; and their related spa types; and HA-MRSA: all other (where ST stands for sequence type and PVL stands for Panton–Valentine leucocidin)]. A mathematical model was applied to determine the genotype-specific transmission rate (i.e. RA) of CA-MRSA and HA-MRSA strains. Results During the 7 year study period there were 117 MRSA index cases with subsequent post-contact screening (of 1108 patients and healthcare workers), revealing 22 outbreaks with a total of 52 secondary patients. RA values were 0.07 (95% CI 0.00–0.28) and 0.65 (95% CI 0.48–0.84) for CA-MRSA and HA-MRSA, respectively. Conclusions In four Danish hospitals the nosocomial transmission rate of CA-MRSA was 9.3 times lower than that of HA-MRSA.
Citation: J Antimicrob Chemother. 2012 Jul;67(7):1775-80. doi: 10.1093/jac/dks125. Epub 2012 Apr 20.
Publication Type: Journal article
Publisher: Journal of Antimicrobial Chemotherapy